Explore our core biotechnology portfolio optimized for nutraceuticals, cosmetics, and specialized personal care formulations.
Creatine Monohydrate (N-(Aminoiminomethyl)-N-methylglycine monohydrate, CAS No. 6020-87-7) represents one of the most thoroughly researched, clinically validated, and commercially pivotal bio-active compounds in modern nutritional science. Historically recognized primarily as an ergogenic aid for explosive anaerobic athletic performance, the compound has undergone a significant paradigm shift over the past decade. Today, pharmaceutical-grade Creatine Monohydrate Powder serves as a cornerstone active raw material across multi-faceted sectors: cognitive health, cellular bioenergetics, sarcopenia prevention in clinical geriatric care, and functional sports beverage ecosystems.
China has solidified its strategic dominance as the premier global hub for Creatine Monohydrate manufacturing. Backed by vertically integrated raw material supply chains—specifically in the synthesis of precursor compounds such as Sodium Sarcosinate and Cyanamide—Chinese manufacturers deliver unrivaled economies of scale, stringent batch-to-batch purity controls, and sophisticated particle engineering capabilities.
However, procuring bulk Creatine Monohydrate at enterprise scale requires navigating complex engineering specifications, chemical impurity profiles (such as controlling toxic byproducts like Dicyandiamide and Dihydrotriazine), mesh size optimization, and global regulatory compliance (FDA GRAS, EFSA, Kosher, Halal, cGMP). This technical whitepaper, curated by Xi'an Le-Nutra Ingredients Inc, delivers an authoritative operational guide for global procurement officers, formulation scientists, and brand owners seeking to leverage Chinese manufacturing capabilities for long-term supply chain resilience.
Strict synthetic process control guarantees HPLC assay purity ≥ 99.9%, with ultralow thresholds for Dicyandiamide (DCD < 20 ppm) and Dihydrotriazine (DHT < 0.5 ppm), complying with European and US Pharmacopeia standards.
Offering customized physical states ranging from standard 80-mesh granular powders for capsules to micro-ionized 200-mesh and 300-mesh powders for instantized RTD beverage solubility.
Fully certified under cGMP, ISO22000, FSSC22000, Kosher, Halal, and FDA GRAS registration, providing seamless regulatory passage into North American and EU markets.
Le-Nutra is a biotechnology enterprise with good reputation in the industry, and has been devoted to natural Ingredients for 14 years.
We are dedicated to the research, production and marketing of Natural, healthy and innovative raw materials widely used in the fields of Nutraceuticals, Foods and Beverages, Cosmetics & Personal Care Products.
We boast a broad product range that includes Botanical Extracts, Plant Proteins, protein hydrolysate actives, moisturizing, emollient, Surfactants, etc.
We have advanced large-scale production equipment and diversified production lines; the facility covers 60,000 square meters with an annual raw material production capacity of 3,000 tons. 6 multifunctional production lines are equipped with different types of extraction tanks, contributing to the process of a wide range of plant materials and the production of raw materials with diversified purities and applications.
With over 10 years of export experience and World-Renowned Customer Cooperation Cases, we have accumulated expert knowledge of this field. Our High-Quality Ingredients and Professional Service have been highly recognized by our customers from over 40 countries, like USA, Canada, UK, France, Germany, Switzerland, Spain, Netherlands, Belgium, Sweden, Thailand, Philippines, Japan, Korea, Russia, Singapore, Indonesia, Brazil...
Le-Nutra focuses on providing innovative raw materials, tailored solutions for its business partners, based on strong R & D capability, extensive experience, and in-depth knowledge of the cosmetic, personal care, and nutraceutical industries.
We have close cooperation with many universities and scientific research institutions at home and abroad. Our Research and Development (R&D) department is comprised of a highly skilled team of professionals, including experienced scientists, engineers, and industry specialists, who are dedicated to advancing plant extraction and small molecule peptide technologies.
The department is equipped with advanced laboratory facilities and analytical instruments that enable accurate testing, analysis, and optimization of extraction processes.
We focus on innovation and continuous improvement, and our team utilizes advanced equipment to ensure the highest quality of plant extracts and small molecule protein peptides. This strong technical base supports our ability to conduct complex research, develop new products, and fine-tune extraction methods to meet specific customer needs.
The manufacturing of industrial-grade and pharmaceutical-grade Creatine Monohydrate requires intricate chemical engineering. The primary commercial reaction mechanism utilized across high-efficiency Chinese chemical plants involves the reaction between Sodium Sarcosinate and Cyanamide in an aqueous alkaline medium.
The reaction proceeds via nucleophilic addition of sarcosine salt to cyanamide under tightly regulated pH (typically between 9.0 and 11.5) and temperature regimes (50°C to 80°C):
Following condensation, the crude product undergoes controlled crystallization, centrifugal separation, multi-stage washing with deionized water, micro-milling, and fluid-bed drying to yield pure Creatine Monohydrate crystalline powder.
During non-optimized chemical synthesis, side reactions can form harmful toxicological byproducts. Global safety guidelines (including EFSA opinion standards) mandate strict limits on two specific impurities:
| Impurity Parameter | Chemical Origin | Health / Toxicity Impact | Le-Nutra Strict Specification Limit |
|---|---|---|---|
| Dicyandiamide (DCD) | Dimerization product of cyanamide raw material under improper pH/temp. | Renal burden, potential cytotoxic irritation at high chronic doses. | < 20 ppm (Typ. < 10 ppm) |
| Dihydrotriazine (DHT) | Cyclization byproduct formed via side reactions of cyanamide derivatives. | Mutagenic concerns; strictly regulated by European Authorities. | Not Detectable (< 0.5 ppm) |
| Creatinine | Thermal degradation product of creatine monohydrate during drying. | Biologically inactive waste product; reduces raw material potency. | < 50 ppm |
| Heavy Metals (Pb, As, Cd, Hg) | Contamination from water systems or upstream reagents. | Systemic organ toxicity; bioaccumulation risk. | Total Heavy Metals < 10 ppm |
The physical state of Creatine Monohydrate dramatically influences its performance in end-user formulations:
Particle Size: ~180 microns (D90 ≤ 180μm)
Characteristics: Superior flowability, low dust formation, high bulk density (~0.65-0.75 g/mL).
Ideal Applications: Hard-shell capsules, tablet compression, bulk container blending where flowability on automated high-speed filling lines is critical.
Particle Size: ≤ 75 microns (D90 ≤ 45-75μm)
Characteristics: Enhanced surface area, ultra-fast dispersion, soft mouthfeel without grittiness.
Ideal Applications: Instantized pre-workout powders, ready-to-mix (RTM) sports drinks, functional stick-packs.
Modern clinical research has expanded Creatine Monohydrate far beyond classical bodybuilding. Leading global brands leverage our raw material to engineer next-generation product lines across diverse health verticals:
Creatine serves as a substrate for phosphocreatine (PCr) storage in skeletal muscle tissue. During high-intensity anaerobic effort, PCr donates a phosphate group to ADP, rapidly regenerating Adenosine Triphosphate (ATP). This increases peak power output, delays neuromuscular fatigue, and accelerates post-exercise glycogen replenishment.
The brain accounts for ~20% of the body's energy consumption despite making up only 2% of body mass. Neuronal creatine kinase activity supports energy homeostasis during intense mental fatigue, sleep deprivation, and complex cognitive tasks. Formulators combine Creatine with Phosphatidylserine or Alpha-GPC for synergy.
Age-related skeletal muscle loss (sarcopenia) and bone density degradation represent major public health challenges. Clinical trials confirm that low-dose daily Creatine supplementation combined with resistance training preserves lean mass, improves balance, and enhances functional independence in elderly populations.
In aqueous environments, Creatine gradually degrades into inactive Creatinine via intramolecular cyclization. Le-Nutra assists beverage developers with micro-encapsulation techniques, pH buffering (maintaining pH ≥ 7.0), and suspension matrix technologies to preserve shelf-life activity in liquid formulations.
As global supply chains face increasing volatility, Xi'an Le-Nutra Ingredients Inc has engineered a modern Industry 4.0 framework across our manufacturing infrastructure. This ensures stable raw material availability, strict traceability, and optimized cost structures for long-term supply partners.
By establishing strategic production alliances with primary chemical plants producing Sodium Sarcosinate and Cyanamide, Le-Nutra remains insulated from raw material price shocks and sudden component shortages, guaranteeing uncompromised lead times.
Our 60,000 m² facility features automated Manufacturing Execution Systems (MES). Distributed Control Systems (DCS) continuously monitor reaction temperatures, crystallization kinetics, and centrifugation speeds in real time to eliminate human error.
Equipped with closed-loop solvent recovery units, high-efficiency wastewater crystallization treatment, and solar-assisted drying systems, our production model minimizes carbon footprint while complying with China's strict environmental regulations.
When evaluating Chinese suppliers for Creatine Monohydrate Powder, corporate procurement managers must execute a rigorous audit protocol. Below is the standardized Quality Assurance (QA) checklist implemented by Xi'an Le-Nutra Ingredients Inc to streamline international customs clearances and regulatory compliance:
| Audit Dimension | Standard Requirement | Le-Nutra Verification Protocol |
|---|---|---|
| HPLC Chemical Purity | ≥ 99.5% Assay | Certified Batch COA via HPLC with inner standard verification (≥ 99.9%). |
| Microbial Safety | Total Plate Count < 1000 cfu/g | Zero Pathogens: Salmonella (Absence/25g), E. coli (Absence/10g), Yeast & Mold < 100 cfu/g. |
| Regulatory Registrations | Target Market Compliance | FDA GRAS Docket listed, EFSA compliant, Kosher Certified, Halal Certified, cGMP facility. |
| Physical Density & Mesh | Customized Granulation | Laser Diffraction Particle Size Analyzer (Malvern) reports provided per batch. |
| Packaging Integrity | Moisture-proof Barrier | 25kg Double Food-Grade PE Liner inside fiber drums or multi-ply Kraft paper bags with heat seals. |
In addition to bulk API supply, Le-Nutra provides turnkey finished product solutions for global brands. Our OEM/ODM capabilities include custom particle blending, flavor synthesis for pre-workout powders, effervescent tablet compression, hard-capsule encapsulation, and automated retail pouch filling.
Technical and procurement queries answered by our senior laboratory scientists and supply chain managers.
Explore additional high-purity raw materials manufactured and exported by Xi'an Le-Nutra Ingredients Inc.
Le-Nutra Ingredients
